Legal developments and practical implications of gene patenting on targeted drug discovery and development.
The use of genetic information to design and guide therapies creates novel patent issues. Gene patents have been integral to the introduction of new biologics, but their role in diagnostic testing is controversial. Genotype-phenotype associations are at the heart of personalized medicine. The intellectual property rules by which these biological relationships are governed have profound implications for the growth of this field. Several cases currently before the courts may add reason and clarity to the law in this area.
Klein
R D
RD
Molecular Oncology, Blood Center of Wisconsin, Milwaukee, Wisconsin, USA. roger.klein@bcw.edu
D016503:Drug Delivery Systems; D015195:Drug Design; D055808:Drug Discovery / Q000331:legislation & jurisprudence / Q000379:methods; D005796:Genes; D005820:Genetic Testing / Q000331:legislation & jurisprudence*; D005838:Genotype; D006801:Humans; D018973:Intellectual Property; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D010641:Phenotype; D057285:Precision Medicine / Q000379:methods